These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 23872176

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of storage condition on properties of MCC II-based pellets with theophylline-monohydrate.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2014 Oct; 88(2):483-91. PubMed ID: 24950003
    [Abstract] [Full Text] [Related]

  • 3. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
    Gómez-Carracedo A, Souto C, Marti Nez-Pacheco R, Concheiro A, Gómez-Amoza JL.
    Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures.
    Kleinebudde P, Schröder M, Schultz P, Müller BW, Waaler T, Nymo L.
    Pharm Dev Technol; 1999 Aug; 4(3):397-404. PubMed ID: 10434285
    [Abstract] [Full Text] [Related]

  • 9. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA.
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of starting material particle size on pellet surface roughness.
    Sarkar S, Ang BH, Liew CV.
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [Abstract] [Full Text] [Related]

  • 13. Influence of the surface tension of wet massing liquid on the functionality of microcrystalline cellulose as pelletization aid.
    Elsergany RN, Lenhart V, Kleinebudde P.
    Eur J Pharm Biopharm; 2020 Aug; 153():285-296. PubMed ID: 32599270
    [Abstract] [Full Text] [Related]

  • 14. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
    Thommes M, Kleinebudde P.
    AAPS PharmSciTech; 2007 Nov 09; 8(4):E95. PubMed ID: 18181555
    [Abstract] [Full Text] [Related]

  • 15. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A, Vetchý D, Janovská L, Krejcová K, Rabisková M.
    Drug Dev Ind Pharm; 2008 Mar 09; 34(3):289-96. PubMed ID: 18363144
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A, De Beer T, Remon JP, Baeyens W, Foreman P, Vervaet C.
    Eur J Pharm Biopharm; 2008 Sep 09; 70(1):302-12. PubMed ID: 18579353
    [Abstract] [Full Text] [Related]

  • 19. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y, Shi CY, Fang JG, Wang WQ.
    Pharm Dev Technol; 2018 Jun 09; 23(5):432-441. PubMed ID: 27882815
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.